• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EQ-5D量表能否衡量精神分裂症患者的生活质量?

Does the EQ-5D measure quality of life in schizophrenia?

作者信息

Halling Hastrup Lene, Nordentoft Merete, Hjorthøj Carsten, Gyrd-Hansen Dorte

机构信息

Psychiatric Research Unit, Region Zealand, Roskilde, Denmark.

出版信息

J Ment Health Policy Econ. 2011 Dec;14(4):187-96.

PMID:22345360
Abstract

BACKGROUND

Most health economic evaluations in mental care include outcome measures aimed at specific aspects of health, like symptom improvement, functional improvement and quality of life instead of generic preference based outcome measures. The health economic guidelines (NICE) recommend to include a generic preference based outcome measure, like EQ-5D, in health economic evaluations in order to allow for comparisons of health related quality of life of patient groups across different diseases, providing information particular useful to support health policy decisions and cost-effectiveness analysis. Although the EQ-5D is by far the most widespread outcome measure within the context of economic evaluations, its validity in psychiatric populations has not yet been established unambiguously. An increasing number of articles have tested the validity of the EQ-5D in comparisons with clinical measures in mental health, but only few studies have addressed the correlation between the EQ-5D and a condition-specific quality of life measure in mental health.

AIMS OF THE STUDY

The aim of the article is to test for a potential correlation between the preferred generic outcome measure in health economic evaluations EQ-5D and Manchester Short Assessment of Quality of Life (MANSA) in order to assess to what extent quality of life dimensions measured by a psychiatric quality of life measure are captured in the EQ-5D in a population of patients with schizophrenia and cannabis abuse.

METHODS

Data analysed is a part of a study of 103 patients with schizophrenia and abuse of cannabis participating in a randomized controlled trial testing a specialized addiction intervention during the period 2008-09. The correlation of the EQ-5D and scores of MANSA was assessed using the Spearman's correlation coefficient. In addition, we tested how the EQ-5D and MANSA correlated with PANSS, GAF and WHO-DAS in order to make comparisons with earlier studies.

RESULTS

We found moderate, statistically significant correlations between the EQ-5D index score and MANSA total score (rho = 0.358**). The dimensions 'Mobility', 'Self-Care' and 'Pain/discomfort' on the EQ-5D were overall not sensitive in this population, while the dimensions 'Usual activities' and 'Anxiety/depression' were moderately correlated with MANSA. The EQ-5D and MANSA both showed statistically significant moderate correlations with the clinical measures in the study PANSS, GAF and WHO-DAS.

DISCUSSION

Our results suggest that the EQ-5D and MANSA are complementary measures rather than substitutes.

IMPLICATIONS FOR HEALTH POLICIES

Mental health interventions often seek to improve the patients' quality of life in a broader perspective, like improving the patients' relationship with family, friends and other network, financial situation, employment and accommodation. If the EQ-5D is used as a single outcome in health economic evaluations of e.g. mental health community interventions, these factors may be overlooked. Based on a relatively small sample, we therefore recommend applying the EQ-5D together with condition-specific quality of life measures in future health economic evaluations in mental health.

摘要

背景

大多数精神卫生保健领域的卫生经济评估所纳入的结果指标旨在针对健康的特定方面,如症状改善、功能改善和生活质量,而非基于偏好的通用型结果指标。卫生经济指南(英国国家卫生与临床优化研究所)建议在卫生经济评估中纳入基于偏好的通用型结果指标,如EQ-5D,以便能够比较不同疾病患者群体的健康相关生活质量,为支持卫生政策决策和成本效益分析提供特别有用的信息。尽管在经济评估背景下,EQ-5D是目前应用最为广泛的结果指标,但其在精神疾病人群中的有效性尚未得到明确证实。越来越多的文章对EQ-5D与精神卫生临床指标进行比较时的有效性进行了测试,但仅有少数研究探讨了EQ-5D与精神卫生领域特定疾病生活质量指标之间的相关性。

研究目的

本文旨在测试卫生经济评估中首选的通用型结果指标EQ-5D与曼彻斯特简易生活质量评估量表(MANSA)之间是否存在潜在相关性,以评估在患有精神分裂症和大麻滥用的患者群体中,精神科生活质量量表所测量的生活质量维度在EQ-5D中得到体现的程度。

方法

所分析的数据是一项针对103名患有精神分裂症和大麻滥用患者的研究的一部分,该研究在2008 - 2009年期间参与了一项测试专门成瘾干预措施的随机对照试验。使用Spearman相关系数评估EQ-5D与MANSA得分之间的相关性。此外,我们还测试了EQ-5D和MANSA与阳性和阴性症状量表(PANSS)、大体功能评定量表(GAF)以及世界卫生组织残疾评定量表(WHO-DAS)之间的相关性,以便与早期研究进行比较。

结果

我们发现EQ-5D指数得分与MANSA总分之间存在中度的、具有统计学意义的相关性(rho = 0.358**)。在该人群中,EQ-5D的“行动能力”“自我照顾”和“疼痛/不适”维度总体上不敏感,而“日常活动”和“焦虑/抑郁”维度与MANSA存在中度相关性。EQ-5D和MANSA与研究中的临床指标PANSS、GAF和WHO-DAS均显示出具有统计学意义的中度相关性。

讨论

我们的结果表明,EQ-5D和MANSA是互补指标而非替代指标。

对卫生政策的启示

精神卫生干预措施通常试图从更广泛的角度改善患者的生活质量,如改善患者与家人、朋友及其他社交网络的关系、财务状况、就业和住宿条件等。如果在例如精神卫生社区干预措施的卫生经济评估中仅将EQ-5D用作单一结果指标,这些因素可能会被忽视。基于相对较小的样本量,因此我们建议在未来精神卫生领域的卫生经济评估中,将EQ-5D与特定疾病生活质量指标一起应用。

相似文献

1
Does the EQ-5D measure quality of life in schizophrenia?EQ-5D量表能否衡量精神分裂症患者的生活质量?
J Ment Health Policy Econ. 2011 Dec;14(4):187-96.
2
Cost-effectiveness analysis in severe mental illness: outcome measures selection.重度精神疾病的成本效益分析:结局指标的选择
J Ment Health Policy Econ. 2007 Jun;10(2):101-8.
3
The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.酒精依赖患者的EQ-5D:健康相关生活质量、精神病理学与社会功能之间的关系。
Drug Alcohol Depend. 2007 Jan 12;86(2-3):253-64. doi: 10.1016/j.drugalcdep.2006.07.001. Epub 2006 Aug 22.
4
A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.一项针对精神分裂症患者的研究中SF-6D与EQ-5D效用评分的比较。
J Ment Health Policy Econ. 2009 Mar;12(1):27-31.
5
Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III.耳鸣患者健康状况评估:EQ-5D 和 HUI 标记 III 的比较。
Ear Hear. 2011 Jul-Aug;32(4):428-35. doi: 10.1097/AUD.0b013e3181fdf09f.
6
Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population.EQ-5D作为海洛因依赖人群通用健康结局工具的效度。
Drug Alcohol Depend. 2006 Apr 28;82(2):111-8. doi: 10.1016/j.drugalcdep.2005.08.012. Epub 2005 Sep 15.
7
The validity of EQ-5D US preference weights in liver transplant candidates and recipients.EQ-5D美国偏好权重在肝移植候选者和接受者中的有效性。
Liver Transpl. 2009 Jan;15(1):88-95. doi: 10.1002/lt.21648.
8
Preference-based quality of life in patients with Alzheimer's disease.阿尔茨海默病患者基于偏好的生活质量
Alzheimers Dement. 2008 May;4(3):193-202. doi: 10.1016/j.jalz.2007.11.019. Epub 2008 May 2.
9
Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.评估类风湿关节炎中的效用值:时间权衡法与欧洲五维度健康量表的比较
Arthritis Rheum. 2006 Oct 15;55(5):751-6. doi: 10.1002/art.22226.
10
Caregivers' assessments of preference-based quality of life in Alzheimer's disease.照顾者对阿尔茨海默病基于偏好的生活质量的评估。
Alzheimers Dement. 2008 May;4(3):203-11. doi: 10.1016/j.jalz.2007.11.018. Epub 2008 Apr 24.

引用本文的文献

1
Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes.精神分裂症的临床结局评估工具:一项以患者报告结局的潜力为重点的范围性文献综述
Innov Clin Neurosci. 2023 Spring;20(4-6):14-33.
2
Comparison of capability and health-related quality of life instruments in capturing aspects of mental well-being in people with schizophrenia and depression.比较用于评估精神分裂症和抑郁症患者心理健康状况的能力及健康相关生活质量工具。
BJPsych Open. 2022 Jun 27;8(4):e117. doi: 10.1192/bjo.2022.514.
3
Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia.
生活质量 8 维度评估量表(AQoL-8D):在癫痫和精神分裂症患者的两项荷兰试验中的翻译、验证和应用。
Expert Rev Pharmacoecon Outcomes Res. 2022 Jul;22(5):795-803. doi: 10.1080/14737167.2021.1981861. Epub 2021 Sep 26.
4
ICER, ISPOR AND QALYs: Tales of Imaginary Worlds.增量成本效果比、药物经济学与质量调整生命年:虚构世界的故事
Innov Pharm. 2019 Oct 31;10(4). doi: 10.24926/iip.v10i4.2266. eCollection 2019.
5
The impact of depression on health-related quality of life and wellbeing: identifying important dimensions and assessing their inclusion in multi-attribute utility instruments.抑郁症对健康相关生活质量和幸福感的影响:确定重要维度并评估其在多属性效用工具中的纳入情况。
Qual Life Res. 2018 Nov;27(11):2873-2884. doi: 10.1007/s11136-018-1936-y. Epub 2018 Jul 13.
6
TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.抗精神病药物在新诊断的精神分裂症或持续性妄想障碍且精神病症状缓解患者中的减量停药与维持治疗对比研究:一项随机临床试验的研究方案
Trials. 2017 Sep 29;18(1):445. doi: 10.1186/s13063-017-2172-4.
7
Measuring quality of life in mental health: are we asking the right questions?衡量心理健康领域的生活质量:我们问对问题了吗?
Soc Sci Med. 2014 Nov;120:12-20. doi: 10.1016/j.socscimed.2014.08.026. Epub 2014 Aug 20.